BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 196 filers reported holding BEAM THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $101,419 | -14.9% | 4,217 | +12.9% | 0.01% | -16.7% |
| Q2 2023 | $119,227 | +10.4% | 3,734 | +5.9% | 0.01% | 0.0% |
| Q1 2023 | $107,966 | -29.7% | 3,526 | -10.2% | 0.01% | -14.3% |
| Q4 2022 | $153,624 | -15.9% | 3,928 | +2.4% | 0.01% | -22.2% |
| Q3 2022 | $182,747 | +23.1% | 3,836 | 0.0% | 0.01% | +28.6% |
| Q2 2022 | $148,492 | -20.6% | 3,836 | +17.5% | 0.01% | 0.0% |
| Q1 2022 | $187,027 | -82.1% | 3,264 | -75.1% | 0.01% | -50.0% |
| Q4 2021 | $1,043,381 | -8.4% | 13,093 | 0.0% | 0.01% | -17.6% |
| Q3 2021 | $1,139,222 | -31.2% | 13,093 | +1.8% | 0.02% | -26.1% |
| Q2 2021 | $1,655,854 | +90.9% | 12,865 | +18.7% | 0.02% | +76.9% |
| Q1 2021 | $867,393 | -5.6% | 10,837 | -3.7% | 0.01% | -7.1% |
| Q4 2020 | $919,185 | +253.8% | 11,259 | +6.7% | 0.01% | +180.0% |
| Q3 2020 | $259,839 | +98.2% | 10,554 | +125.4% | 0.01% | +150.0% |
| Q2 2020 | $131,096 | +55.6% | 4,682 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $84,276 | – | 4,682 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
| HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
| DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
| Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
| Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
| Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
| HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
| Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
| ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
| BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |